3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Recurrence
1
Neoplasms
1
Mouth Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Head and Neck Neoplasms
1
Interventions
asciminib
10
Cyclophosphamide
9
Mycophenolic Acid
7
fludarabine
5
Whole-Body Irradiation
5
nilotinib
4
fludarabine phosphate
4
Stem Cell Transplantation
4
Specimen Handling
4
Dasatinib
4
olverembatinib
3
bosutinib
3
Imatinib Mesylate
3
Cyclosporine
3
venetoclax
2
ponatinib
2
blinatumomab
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Sirolimus
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Hematopoietic Stem Cell Transplantation
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporins
2
Bone Marrow Transplantation
2
Blood Component Removal
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
High-Throughput Nucleotide Sequencing
×
Clear all
NCT05605379
2024-08-14
CML Piramid
University Hospital, Bordeaux
Recruiting
88 enrolled